Rapid Intradermal Delivery of Liquid Formulations Using a Hollow Microstructured Array
Overview
Authors
Affiliations
Purpose: The purpose of this work is to demonstrate rapid intradermal delivery of up to 1.5 mL of formulation using a hollow microneedle delivery device designed for self-application.
Methods: 3M's hollow Microstructured Transdermal System (hMTS) was applied to domestic swine to demonstrate delivery of a variety of formulations including small molecule salts and proteins. Blood samples were collected after delivery and analyzed via HPLC or ELISA to provide a PK profile for the delivered drug. Site evaluations were conducted post delivery to determine skin tolerability.
Results: Up to 1.5 mL of formulation was infused into swine at a max rate of approximately 0.25 mL/min. A red blotch, the size of the hMTS array, was observed immediately after patch removal, but had faded so as to be almost indistinguishable 10 min post-patch removal. One-mL deliveries of commercial formulations of naloxone hydrochloride and human growth hormone and a formulation of equine anti-tetanus toxin were completed in swine. With few notable differences, the resulting PK profiles were similar to those achieved following subcutaneous injection of these formulations.
Conclusions: 3M's hMTS can provide rapid, intradermal delivery of 300-1,500 µL of liquid formulations of small molecules salts and proteins, compounds not typically compatible with passive transdermal delivery.
Beyond the Needle: Innovative Microneedle-Based Transdermal Vaccination.
Nguyen H Medicines (Basel). 2025; 12(1).
PMID: 39982324 PMC: 11843882. DOI: 10.3390/medicines12010004.
Advancements in Skin-Mediated Drug Delivery: Mechanisms, Techniques, and Applications.
Lee D, Lim S, Kwak S, Kim J Adv Healthc Mater. 2023; 13(7):e2302375.
PMID: 38009520 PMC: 11468599. DOI: 10.1002/adhm.202302375.
Live-Attenuated VEEV Vaccine Delivered by iDNA Using Microneedles Is Immunogenic in Rabbits.
Tretyakova I, Tomai M, Vasilakos J, Pushko P Front Trop Dis. 2023; 3.
PMID: 37854093 PMC: 10583749. DOI: 10.3389/fitd.2022.813671.
Futaki M, Inamura K, Hashimoto M, Motegi S, Itakura S, Sugibayashi K Pharm Res. 2023; 40(8):1953-1963.
PMID: 37165148 DOI: 10.1007/s11095-023-03529-6.
Microneedle-Mediated Transdermal Delivery of Biopharmaceuticals.
Nguyen H, Nguyen C Pharmaceutics. 2023; 15(1).
PMID: 36678906 PMC: 9864466. DOI: 10.3390/pharmaceutics15010277.